Learn what to expect before, during, and after surgery for excision of benign soft-tissue tumors — including preparation, procedure details, recovery, and follow-up care.
Latest News
Uncategorized
Cryosurgery for Bone and Soft-Tissue Tumors: How Freezing Technology Helps Treat Cancer
Cryosurgery is an advanced, minimally invasive treatment that uses extreme cold to destroy bone and soft tissue tumors. Learn how freezing technology helps target cancer cells while preserving healthy tissue and supporting faster recovery.
The Future Is Now: 2025 Trends Revolutionizing Orthopedic Oncology
Orthopedic oncology is rapidly evolving, driven by breakthroughs in personalized medicine, genetic profiling, and targeted therapies. Explore how 2025’s advancements are reshaping bone cancer treatment and offering new hope to patients with musculoskeletal tumors.
It Takes a Very Special Team: Orthopedic Oncology Is a Mission and a Passion
Orthopedic oncology isn’t just a specialty; it’s a calling. In this Ortho Show podcast, Dr. James C. Wittig reflects on the teamwork, mentorship, and mission that inspire him to help children with cancer overcome extraordinary challenges and live full, thriving lives.
A New Era in Orthopedic Oncology Education: How Dr. James C. Wittig and Mandala Media Are Transforming Patient Learning
The launch of the Orthopedic Oncology media platform marks a new chapter in patient education and empowerment. Developed by Mandala Media and Dr. James C. Wittig, the platform connects clinical expertise, innovation, and storytelling to make orthopedic oncology knowledge accessible to all.
Mandala Media Launches Orthopedic Oncology Global, a Digital Media Platform Featuring Renown Orthopedic Oncologist, Surgeon, and Medical Innovation Leader Dr. James C. Wittig
Mandala Media has launched Orthopedic Oncology, a new digital media platform created in collaboration with Dr. James C. Wittig. The platform delivers trusted educational resources, expert insight, and inspiring patient stories to help those affected by bone and soft tissue tumors.
Conventional Chondrosarcoma! Rare Primary Bone Cancer but the 2nd Most Common Bone Sarcoma: Presentation, Radiology, Pathology, Treatment and Prognosis
Conventional chondrosarcoma is a rare primary bone cancer and the second most common bone sarcoma. Dr. James C. Wittig explains its presentation, radiology, pathology, treatment, prognosis, and the latest clinical research findings.
Advancing Knowledge in Musculoskeletal Pathology: Dr. James C. Wittig Contributes to the 27th Annual Mount Sinai Course
Dr. James C. Wittig, founder of the Mount Sinai Musculoskeletal Pathology Course, participated as a 2025 presenter. His lecture on malignant cartilage tumors and case discussions advanced global knowledge in orthopedic oncology, underscoring his dual role as surgeon and educator.
After Every Other Hospital in the NYC Metro Said Amputation was the Only Course, Dr. Wittig Successfully Removed a Massive Tumor and Rebuilt the Leg
Globally renowned musician and photographer Tom Artin recounts his experience with PVNS and how Dr. James C. Wittig performed limb sparing knee surgery, removing the tumor, rebuilding his leg, and preserving his mobility when other doctors recommended amputation.
Three Years On, a Baby Girl Thrives After Limb-Sparing Surgery for Ultra-Rare Ewing Sarcoma
Three years after undergoing limb sparing surgery for Ewing sarcoma, a rare bone cancer, Dr. James C. Wittig’s infant patient is thriving. The case highlights how advanced orthopedic oncology can preserve function, growth, and quality of life.